Aarti Pharmalabs Limited (BOM:543748)

Market Cap	88.41B +18.0%
Revenue (ttm)	19.69B +1.2%
Net Income	2.05B -23.1%
EPS	22.56 -23.2%
Shares Out	n/a
PE Ratio	43.17
Forward PE	59.46
Dividend	3.50 (0.36%)
Ex-Dividend Date	Sep 15, 2026

Volume	61,360
Open	960.00
Previous Close	947.00
Day's Range	955.65 - 986.55
52-Week Range	583.85 - 1,001.55
Beta	n/a
Analysts	n/a
Price Target	n/a
Est. Earnings	Oct 28, 2026

About Aarti Pharmalabs

Aarti Pharmalabs Limited, together with its subsidiaries, manufactures and sells active pharmaceutical ingredients, pharmaceutical intermediates, and xanthine derivatives in India and internationally. The company offers active pharmaceutical ingredients for various therapeutic areas, such as cardiovascular, anti-asthmatic, anti-cancer, anti-coagulant, anti-diabetic, arthritis, central nervous system agent, skincare, overactive bladder, calcimimetic, decongestant, anti-thalassaemic, analgesic, ophthalmologic, antidepressant medications. It also ...

• Industry: Pharmaceutical Preparations
• Founded: 2019
• Employees: 2,421
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 543748

Financial Performance

In fiscal year 2026, Aarti Pharmalabs's revenue was 18.19 billion, a decrease of -13.98% compared to the previous year's 21.15 billion. Earnings were 1.75 billion, a decrease of -35.86%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Oct 7, 2026

Data Sources Report a data error